Enanta Pharmaceuticals Inc (ENTA)

[vinmantoo]

What if Enanta did a 6 day versus 5 day (or 5 and 6 day cohorts) and there were no rebounds, even in a larger pool?

In the just completed EDP-235 trials, some of the dosing was for 7 days.

So both Fauci and now Biden have rebounded. I agree that it may not be a serious problem, but it may pose an opportunity.

Agreed.

Getting to your second point- an approved drug that doesn't use Ritonavir may be more likely to be approved immediately by a doctor or pharmacist- thereby treating more immediately, having lower viral loads, less secondary immune/inflammation reactions, a quicker and more complete recovery. That may be more true for the older or more immune compromised or those with other co-morbidities. That's where we are really seeing the serious health consequences.

In short- there looks like there is a lot of need and potential upside to EDP-235.

Agreed.